Trial
NCT02560051
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Prostatic Neoplasms
Intervention
Doxorubicin
Why stopped
Slow accrual; resource re-allocation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-28